Kupando
PrivateLast Round
Series A
Extension
Mar 18, 2026
Total Funding Raised
$24.09M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kupando is a biopharmaceutical company developing small-molecule immunotherapies that stimulate the innate immune system to address unmet needs in oncology and infectious diseases.
Sector
Consumer & Commerce
Verticals
E-commerce, Supply Chain, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kupando Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Kupando Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 18, 2026 | ||||
| Series A | Sep 26, 2022 |
Kupando Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A Extension |
| LifeCare Partners | Series A Extension, Series A |
| Remiges Ventures | Series A Extension, Series A |
| Brandenburg Kapital | Series A Extension, Series A |
| Ventura BioMed Investors | Series A Extension, Series A |
| CARMA FUND | Series A Extension |
| High-Tech Gründerfonds | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$11.5M raised in Series A Extension round.
Kupando Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kupando's valuation, stock price, and market status.